Assessment of a remote symptom monitoring in haematological cancer patients - a randomised controlled trial
Not Applicable
Not yet recruiting
- Conditions
- Monitoring symptoms in haematological cancer patientsCancer - Lymphoma (non Hodgkin's lymphoma) - Low grade lymphomaCancer - Leukaemia - Chronic leukaemiaCancer - Hodgkin's
- Registration Number
- ACTRN12611000186954
- Lead Sponsor
- Peter MacCallum Cancer Centre
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not yet recruiting
- Sex
- All
- Target Recruitment
- 320
Inclusion Criteria
Have a diagnosis of one of three haematological cancers (Hodgkin's lymphoma, Non-hodgkin's lymphoma or Chronic Lymphocytic Leukemia)
Be receiving four or more cycles of chemotherapy treatment in a day treatment unit
Be over 18 years of age
Exclusion Criteria
Having a key cognitive psychological disorder as assessed by the treatmetn team
Unable to speak/read/write English
Participating in a clinical drug trial
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Psychological distress: Hospital Anxiety and Depression Scale Total Score<br>Completed with Patient Self Report in a questionnaire booklet[At completion of 2 cycles of chemotherapy, three cycles and four cycles.]
- Secondary Outcome Measures
Name Time Method